Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 4/2009

01-04-2009 | Research Articles

Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study)

Authors: Ignasi Tusquets, Enrique Espinosa Arranz, Miguel Méndez, J. Miquel Gil, José Luis Guallar, Núria Perulero

Published in: Clinical and Translational Oncology | Issue 4/2009

Login to get access
Metadata
Title
Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study)
Authors
Ignasi Tusquets
Enrique Espinosa Arranz
Miguel Méndez
J. Miquel Gil
José Luis Guallar
Núria Perulero
Publication date
01-04-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 4/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-009-0344-8

Other articles of this Issue 4/2009

Clinical and Translational Oncology 4/2009 Go to the issue

Case Reports

Retroperitoneal tumour radiotherapy: clinical improvements using kilovoltage cone beam computed tomography

Case Reports

Peritoneal solitary fibrous tumour (SFT): long-term survival of recurrent and metastasised SFT treated with cytoreductive surgery and intraperitoneal chemotherapy

Editorial

Continuing medical education (CME) or continuing professional development (CPD): a need, a challenge, but also a must

Research Articles

The EORTC cancer in-patient satisfaction with care questionnaire: EORTC IN-PATSAT32

Correspondence

Synchronous isolated adrenal metastasis from rectum adenocarcinoma

Research Articles

Chemopreventive efficacies of rosiglitazone, fenretinide and their combination against rat mammary carcinogenesis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits